CLASSIC HODGKIN LYMPHOMA
Clinical trials for CLASSIC HODGKIN LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new CLASSIC HODGKIN LYMPHOMA trials appear
Sign up with your email to follow new studies for CLASSIC HODGKIN LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for frail hodgkin lymphoma patients ineligible for standard care
Disease control Not yet recruitingThis study is testing a combination of immunotherapy and chemotherapy for frail adults newly diagnosed with Hodgkin lymphoma who are not healthy enough for the usual first-line treatment. The goal is to see if this alternative approach can safely and effectively control the cance…
Matched conditions: CLASSIC HODGKIN LYMPHOMA
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
Blood test guides fight against stubborn lymphoma
Disease control Not yet recruitingThis study is testing a combination of four drugs (pembrolizumab, gemcitabine, vinorelbine, and liposomal doxorubicin) for adults whose classic Hodgkin lymphoma has returned or not responded to initial treatment. It aims to see if this treatment can achieve a deep remission, meas…
Matched conditions: CLASSIC HODGKIN LYMPHOMA
Phase: PHASE2 • Sponsor: Michael Spinner, MD • Aim: Disease control
Last updated Mar 19, 2026 14:55 UTC